US 7081529
Recombinant vaccine against botulinum neurotoxin
granted A61KA61K39/00A61K39/08
Quick answer
US patent 7081529 (Recombinant vaccine against botulinum neurotoxin) held by The United States of America as represented by the Secretary of the Army expires Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Secretary of the Army
- Grant date
- Tue Jul 25 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K39/00, A61K39/08